{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:05Z","timestamp":1792664645369,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijid.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T11:50:33Z","timestamp":1550490633000},"page":"221-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-7770","authenticated-orcid":false,"given":"Charles","family":"Abongomera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullia","family":"Battaglioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherinet","family":"Adera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Ritmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.02.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006527","article-title":"The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: a retrospective cohort study","volume":"12","author":"Abongomera","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/cix607","article-title":"The risk and predictors of visceral leishmaniasis relapse in human immunodeficiency virus-coinfected patients in Ethiopia: a retrospective cohort study","volume":"65","author":"Abongomera","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163047","article-title":"A comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post kala azar dermal leishmaniasis in South Sudan \u2014A retrospective cohort study","volume":"11","author":"Abongomera","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2019.02.012_bib0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2019.02.012_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1179\/136485906X91440","article-title":"Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy","volume":"100","author":"Belay","year":"2006","journal-title":"Ann Trop Med Parasitol."},{"key":"10.1016\/j.ijid.2019.02.012_bib0030","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0035","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.02.012_bib0040","series-title":"Short course regimens for treatment of PKDL (Sudan) [Internet]","author":"Drugs for Neglected Diseases Initiative","year":"2018"},{"key":"10.1016\/j.ijid.2019.02.012_bib0045","first-page":"1","article-title":"Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies","volume":"XX","author":"Mondal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0050","article-title":"Decline in clinical efficacy of oral miltefosine in treatment of post kala-azar dermal leishmaniasis (PKDL) in India","volume":"9","author":"Ramesh","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0055","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.012_bib0060","series-title":"Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach [Internet]","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.ijid.2019.02.012_bib0065","series-title":"Control of the leishmaniases. [Internet]. WHO technical report series","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ijid.2019.02.012_bib0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13071-016-1721-0","article-title":"The immunology of post-kala-azar dermal leishmaniasis (PKDL)","volume":"9","author":"Zijlstra","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ijid.2019.02.012_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:18:44Z","timestamp":1561097924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":15,"alternative-id":["S1201971219300761"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}